IGC Pharma, Inc.IGCNYSE
Loading
Year-over-year SG&A expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -34.74% |
| 2024 | -15.02% |
| 2023 | -40.17% |
| 2022 | 78.51% |
| 2021 | 24.77% |
| 2020 | 69.59% |
| 2019 | 88.18% |
| 2018 | -17.69% |
| 2017 | -15.95% |
| 2016 | -34.71% |